Quoin Pharmaceuticals (QNRX) Payables (2017 - 2026)

Quoin Pharmaceuticals has disclosed Payables across 10 years of filings, most recently posting $3.1 million for Q2 2026.

• In Q2 2026, Payables rose 255.91% year-over-year to $3.1 million; the TTM figure through Jun 2026 stood at $3.1 million (up 255.91% YoY), while the FY2025 annual figure was $1.3 million, up 39.36% from the prior year.
• Payables came in at $3.1 million for Q2 2026 at Quoin Pharmaceuticals, up from $1.8 million in the prior quarter.
• In the past five years, Payables ranged from a high of $5.2 million in Q2 2022 to a low of $222636.0 in Q3 2024.
• Average Payables over 5 years is $1.9 million, with a median of $905704.0 recorded in 2024.
• Year-over-year, Payables tumbled 94.73% in 2023 and surged 735.77% in 2025.
• Over 5 years, Payables stood at $4.7 million in 2022, then tumbled by 88.87% to $526523.0 in 2023, then soared by 72.02% to $905704.0 in 2024, then surged by 39.36% to $1.3 million in 2025, then surged by 146.35% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.1 million in Q2 2026, $1.8 million in Q1 2026, and $1.3 million in Q4 2025.